Global Cancer Institute

What Global Cancer Institute does

Global Cancer Institute (GCI) is a 501(c)(3) nonprofit organization founded in 2013 by Dr. Paul Goss and headquartered in Boston, Massachusetts. It operates a portfolio of programs targeting cancer outcome disparities in low- and middle-income countries (LMICs), where mortality rates are roughly double those in the United States. The organization's core programs include monthly Global Tumor Board videoconferences connecting 850+ physicians across 30+ countries with U.S. expert panels, Patient Navigation Programs deployed in hospitals in Mexico and Brazil, the GCI Fellows Program that has trained 80 early-career oncologists from 32 countries since 2012, and the Young Women's Global Breast Cancer Database that collects clinical and epidemiological data via low-cost tablet-based questionnaires.

Name

Global Cancer Institute

Legal name

Global Cancer Institute, Inc.

Website

https://globalcancerinstitute.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

GCI is a 501(c)(3) nonprofit operating Global Tumor Boards, Patient Navigation Programs, and the Young Women's Breast Cancer Database to improve cancer survival rates for underserved patients in low- and middle-income countries across 30+ nations.

Ownership category

akta.pro rank

Product category

Global Oncology Services (Nonprofit Healthcare Capacity-Building)

NAICS

Scientific Research and Development Services (5417), Other Individual and Family Services (624190)

SIC

Services-Health Services (8000), Services-Educational Services (8200)

akta.pro primary industry

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Global cancer care
• Patient navigation services
• Oncology training programs
• Tumor board meetings
• Cancer research database

Headquarters

HQ city

Short Hills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: As a 501(c)(3) nonprofit organization, GCI generates revenue primarily through donations from individuals, foundations, and corporate partners. The organization accepts donations through PayPal and provides tax deductions for U.S. donors.
2. Foundation and Grant Funding: GCI receives support from foundations such as the Avon Breast Cancer Crusade, which previously contributed up to $40 million annually in related women's health programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Global Cancer Institute works directly with healthcare providers in developing countries to deliver programs that improve clinical practice patterns and accelerate access to timely diagnosis and high-quality cancer treatment. Its portfolio centers on Global Tumor Boards (live case-based videoconferences with U.S. expert panels), Patient Navigation Programs (trained navigators helping patients overcome fragmented-system barriers), the GCI Fellows Program (LMIC oncologist scholarships), and the Young Women's Global Breast Cancer Database (epidemiological research data collection).

Product overview

Global Cancer Institute (GCI) operates as a portfolio of interconnected healthcare access programs rather than a unified software product. Its core offerings include: Global Tumor Boards (monthly videoconference sessions connecting developing-world physicians with U.S. multidisciplinary expert panels); Patient Navigation Programs (trained navigators helping patients overcome health system barriers); the GCI Fellows Program (international scholarships for young oncologists); Health Policy Initiatives (engagement with policymakers); Genetic Testing Programs (expanding access to hereditary cancer testing); the Young Women's Global Breast Cancer Database (epidemiological research data collection via tablets); and Clinical Care Surveys (assessment of global cancer care practices). These programs work synergistically to address the gap between cancer care in developed and developing countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Global Tumor Boards Monthly videoconference meetings connecting physicians and oncologists in developing countries with multidisciplinary expert panels from U.S. and other developed-country cancer centers to discuss complex cancer cases and share clinical expertise.
• Patient Navigation Programs Programs that help cancer patients in low-resource hospital systems overcome barriers to timely, high-quality care by pairing them with navigators who assist with scheduling, insurance navigation, and system coordination.
• GCI Fellows Program Scholarship program bringing promising early-career oncologists from low- and middle-income countries to U.S.-based cancer centers for clinical practice, education, and research exposure.
• Young Women's Global Breast Cancer Database Low-cost database collecting clinical and epidemiological data from young breast cancer patients globally, including lifestyle factors, genetic risk, psychological needs, quality of life, and clinical characteristics.
• Clinical Care Surveys Widespread surveys conducted with global doctors using accepted cancer care guidelines to assess practices, knowledge gaps, and disparities across regions, producing a baseline snapshot of cancer care status.
• Genetic Testing Programs Programs to improve access to genetic testing for hereditary cancer syndromes in underserved populations.
• Health Policy Initiatives Engagement with health policy makers to drive widespread change in cancer control through policy development and implementation.

Quantifiable outcome

• Reduced median time from diagnosis to referral from 2 months to 11 days in Mexico City pilot
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered minor, core and supporting.

• Melanoma Research AllianceminorOthers · 8 April 2022Carolyn Ricci, GCI's Executive Director, previously served as Director of Development at the Melanoma Research Alliance before joining GCI. This represents a talent connection rather than an active partnership.
• Avon InstitutecoreStrategic or Co-development Partner · 26 May 2020Collaborated on a Facebook Live discussion about patient navigation in the Brazilian context. The Avon Institute co-organized and hosted the discussion with GCI and Fundação Laço Rosa.
• Fundação Laço RosasupportingStrategic or Co-development Partner · 26 May 2020Brazilian nonprofit organization that co-hosted the Facebook Live discussion on patient navigation with GCI and Avon Institute. Partner organization focused on breast cancer advocacy in Brazil.
• Avon Breast Cancer CrusadecoreStrategic or Co-development Partner · 8 April 2012Long-standing partnership with the Avon Breast Cancer Crusade, where Carolyn Ricci previously led strategy and grantmaking for up to $40 million in annual giving. The partnership has supported GCI's programs including the Global Tumor Boards and Fellows Program. Avon Scholars program and related initiatives have been co-developed through this relationship.
• Sandra San MiguelsupportingOthersResearcher and coordinator for cancer patient navigation programs among Latino populations in the U.S. Led patient navigation training in Mexico City, emphasizing empathy, emotional support, and patient empowerment.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PATH: PATH is a global non-profit advancing health equity through innovation and partnerships in LMICs. Comparable to GCI in its NGO operating model, focus on low-resource health systems, and emphasis on training and capacity-building at the provider level.
• Partners in Health: Partners in Health is a global health non-profit delivering health services and training in resource-poor settings. Directly comparable to GCI in its model of pairing on-the-ground clinical training and system-strengthening with North American medical expertise.
• Union for International Cancer Control (UICC): UICC is the largest international membership-based cancer-control organization, convening NGOs, governments, and experts to reduce the global cancer burden. Highly comparable to GCI in its global cancer-control NGO positioning and convening role across LMICs.
• LIVESTRONG Foundation: LIVESTRONG is a U.S.-based cancer-focused non-profit that funds programs, advocacy, and survivorship services. Comparable to GCI as a cancer-focused non-profit driving patient outcomes and program funding, though its geographic scope is more U.S.-centric.
• City Cancer Challenge (C/Can): C/Can is a global health non-profit focused on improving cancer care in cities in low- and middle-income countries through city-wide stakeholder partnerships. Closely comparable to GCI in mission, LMIC focus, and partnership-driven delivery model.
• Susan G. Komen: Susan G. Komen is a major breast cancer non-profit funding research, community health, and global programs. Comparable to GCI in its breast-cancer focus, donor-funded model, and funding of international patient-navigation and screening initiatives.

Broad incumbents

• National Cancer Institute (NCI): NCI is the U.S. government's principal agency for cancer research and training, with international research collaborations. A broader incumbent in global cancer control, comparable to GCI in research and training mission but vastly larger in scope and resources.
• American Cancer Society: The American Cancer Society is a large U.S. cancer non-profit with significant global health and LMIC programs. A broader incumbent comparable to GCI in cancer mission and donor-driven model, but with materially larger scale, staff, and budget.
• American Society of Clinical Oncology (ASCO): ASCO is the leading professional society for oncologists, operating international education, training, and capacity-building programs. Comparable to GCI in convening oncologists and delivering global oncology education, but as a much larger professional membership organization.

Emerging players

• Clinton Health Access Initiative (CHAI): CHAI is a global health non-profit working with governments and partners to expand access to quality health services, including cancer. Comparable to GCI as a multi-country health-equity organization operating in LMICs, but focused on broader health-system and market-access interventions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/thegci
• Facebookfacebook.com/GlobalCancerInstitute

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Global Cancer Institute